Hemoptysis in the Outpatient Setting Most (72 percent) respondents held chronic bronchitis to be the major cause of mild hemoptysis; other selections included lung cancer (11 percent), idiopathic causes (“essential” or “cryptogenic”) (7 percent), tuberculosis (5 percent), and bronchiectasis (5 percent). Most (91 percent) advocated fiberoptic bronchoscopy of a 55-year-old, 80 pack-year cigarette smoker with [...]
The demographic characteristics of participants and their responses to questions about mild hemoptysis in ambulatory outpatients and life-threatening hemoptysis in critically ill individuals were recorded. Responses were entered on as many as 118 keypads, with a mean±SD of 104 ±9.1 responses per question. Seventy-nine individuals responded to over 80 percent of questions. Data from all [...]
Physicians attending an interactive session at the 1988 Annual Scientific Assembly of the ACCP answered a series of questions about the diagnosis and management of patients with hemoptysis. Responses were recorded by computer, and the proportions of answers to multiple-choice questions were tabulated for immediate feedback to the audience. Participants selected a single best answer [...]
Temoptvsis is a symptom and sign commonly evaluated by chest clinicians. Despite considerable emphasis upon the approaches to this problem and its diverse presentations, several questions remain: the selection of ambulatory patients for bronchoscopy and other diagnostic studies, the optimum approaches to the emergency support of individuals with life-threatening bleeding, and the best applications of [...]
We treated all CMV seronegative recipients irrespective of donor serology with anti-CMV immunoglobulins from the day of transplantation. Arguments for this strategy were that the CMV serology of the donor is not always available at the time of transplantation and that CMV unscreened (although bufly coat poor) blood is used during open heart surgery. Moreover, [...]
In Table 1, the characteristics of the 77 heart transplant recipients are shown. A total of 41 of 77 (53 percent) patients were CMV seropositive at the time of transplantation. Twenty of the 36 CMV seronegative patients received an allograft from a seropositive donor. One CMV seronegative patient received two allografts, the first from a [...]
During a period of four years, heart transplantations were performed in 77 patients. The immunosuppressive regimen consisted of cyclosporin A (CsA) and prednisone. The dose of CsA was adjusted according to plasma trough levels. Endomyocardial biopsies were performed at regular intervals. In case of a biopsy-proven rejection three times, 1 g of methylprednisolone was administered [...]